Independent advisers to the US Centers for Disease Control and Prevention (CDC) will meet later this month to make recommendations on booster doses of Moderna and Johnson & Johnson's COVID-19 vaccines, the agency said on Friday, according to Reuters.
The meetings, on October 20-21, are scheduled a week after advisers to the US Food and Drug Administration weigh in on the need for booster doses of the two vaccines.
Johnson & Johnson on Tuesday asked the FDA to authorize booster shots of its single dose COVID-19 vaccine for people over the age of 18.
Last month, the FDA authorized a booster dose of the Pfizer and BioNTech vaccine for older adults and some Americans at high-risk of illness.
The CDC panel, called Advisory Committee on Immunization Practices, will also discuss COVID-19 vaccines for children on November 2 and 3, an agency spokesperson said, according to Reuters.
Those meetings are also scheduled a week after FDA advisers review the need for Pfizer's COVID-19 vaccine in children aged five to 11.
The CDC’s announcement came a day after Pfizer asked US regulators to authorize emergency use of their COVID-19 vaccine for children ages 5 to 11.
Last month, Pfizer announced that its COVID-19 vaccine has been proven safe and effective in Phase 2/3 clinical trials for this age group.
(Arutz Sheva’s North American desk is keeping you updated until the start of Shabbat in New York. The time posted automatically on all Arutz Sheva articles, however, is Israeli time.)